(September 27 18:16) Forbes.com
Mammoth Biosciences has raised $195 million to build next-generation CRISPR products in therapeutics and diagnostics that can cure and detect diseases. Mammoth has now reached unicorn status in the industry with a valuation of more than $1 billion.
You can find the original article
here